Presentation is loading. Please wait.

Presentation is loading. Please wait.

静岡県立大学 薬学部 薬物動態学分野 Department of Pharmacokinetics and Pharmacodynamics School of Pharmaceutical Sciences, University of Shizuoka Hiroki Suzuki Tuesday,

Similar presentations


Presentation on theme: "静岡県立大学 薬学部 薬物動態学分野 Department of Pharmacokinetics and Pharmacodynamics School of Pharmaceutical Sciences, University of Shizuoka Hiroki Suzuki Tuesday,"— Presentation transcript:

1 静岡県立大学 薬学部 薬物動態学分野 Department of Pharmacokinetics and Pharmacodynamics School of Pharmaceutical Sciences, University of Shizuoka Hiroki Suzuki Tuesday, January 12, 2016 Data presentation

2 UNIVERSITY OF SHIZUOKA  Developing various powder formulation using fine droplet drying process for improvement in biopharmaceutical properties of drugs  Model compound:Cyclosporine A (CsA) 1. Potent immune suppression effect 2. Low solubility (ca. 20  g/mL in water) Collaborative study with RICOH company Working hypothesis HPC-SSL-based amorphous solid dispersion of CsA (ASD/CsA) with improved dissolution may show the enhanced oral absorption. 2 Main purpose This study mainly aims to clarify the feasibility of fine droplet drying process for the production of ASD formulation.

3 UNIVERSITY OF SHIZUOKA Characterization of ASD/CsA 3 Dissolution behavior Pharmacokinetic behavior in rats ▲ASD/CsA ■Amorphous CsA Mean±SE (n=3).Mean±SE (n=6). Test conditions Test solution: 100 mL of distilled water Applied sample: 3 mg-CsA/100 mL Rotation: 100 rpm Temperature: 37 º C

4 UNIVERSITY OF SHIZUOKA 3 Dissolution behavior Pharmacokinetic behavior in rats ▲ASD/CsA (10 mg-CsA/kg, p.o.) ■Amorphous CsA (10 mg-CsA/kg, p.o.) C max (ng/mL)T max (h)T 1/2 (h) AUC 0-inf (h·ng/mL) BA (%) ASD/CsA (10 mg-CsA/kg, p.o.) 1,000±1305.2±1.67.2±2.113,000±2,13014.6 Amorphous CsA (10 mg-CsA/kg, p.o.) 100±503.7±0.42.7±0.3560±2500.6 Pharmacokinetic parameters Mean±SE (n=6). Mean±SE (n=3).Mean±SE (n=6). Characterization of ASD/CsA

5 UNIVERSITY OF SHIZUOKA 3 Dissolution behavior Pharmacokinetic behavior in rats ▲ASD/CsA (10 mg-CsA/kg, p.o.) ■Amorphous CsA (10 mg-CsA/kg, p.o.) Mean±SE (n=3).Mean±SE (n=6). The ASD/CsA exhibited higher dissolution behavior and oral absorption of CsA than amorphous CsA. Characterization of ASD/CsA

6 UNIVERSITY OF SHIZUOKA 3 Dissolution behavior Pharmacokinetic behavior in rats ▲ASD/CsA (10 mg-CsA/kg, p.o.) ■Amorphous CsA (10 mg-CsA/kg, p.o.) Mean±SE (n=3).Mean±SE (n=6). Future plan Physicochemical stability of ASD/CsA Conditions:40ºC/75% relative humidity for 2, 4, and 8 weeks Assessments:Crystallinity Dissolution behavior Characterization of ASD/CsA


Download ppt "静岡県立大学 薬学部 薬物動態学分野 Department of Pharmacokinetics and Pharmacodynamics School of Pharmaceutical Sciences, University of Shizuoka Hiroki Suzuki Tuesday,"

Similar presentations


Ads by Google